Mechanisms of the systemic inflammatory response

Perfusion

Volumn 14, Issue 4, 1999, Pages 269-277

  Asimakopoulos, George ^a  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 7; CELL ADHESION MOLECULE; CHEMOKINE; COMPLEMENT; CYTOKINE;

CARDIOPULMONARY BYPASS; CARDIOVASCULAR DISEASE; CELL ACTIVATION; COMPLEMENT ACTIVATION; CONFERENCE PAPER; ENDOTHELIUM CELL; HEART MUSCLE INJURY; HEART SURGERY; HUMAN; INFLAMMATION; INTESTINE FLORA; INTESTINE FUNCTION; INTESTINE ISCHEMIA; KIDNEY DISEASE; LEUKOCYTE COUNT; LUNG DISEASE; MONOCYTE; MULTIPLE ORGAN FAILURE; NEUTROPHIL; PRIORITY JOURNAL;

EID: 0032810874     PISSN: 02676591     EISSN: None     Source Type: Journal    
DOI: 10.1177/026765919901400406     Document Type: Conference Paper

References (85)

1. Bone RC, Balk RA, Cerra FB et al. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: Definition for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 1992; 20: 864-68.
2. Butler J, Rocker GM, Westaby S. Inflammatory response to cardiopulmonary bypass. Ann Thorac Surg 1993; 55: 552-59.
3. Ohri SK. Systemic inflammatory response and the splanchnic bed in cardiopulmonary bypass. Perfusion 1996; 11: 200-12.
4. Kolff WJ, Effler DB, Groves LK. Pulmonary complications of open heart operations. Their pathogenesis and avoidance. Cleve Clin Q 1958; 25: 65-83.
5. Braude S, Nolop KB, Fleming JS, Krausz T, Taylor KM, Royston D. Increased pulmonary transvascular protein flux after canine cardiopulmonary bypass. Am Rev Respir Dis 1986; 134: 867-72.
6. Messent M, Sinclair DG, Quinlan GJ, Mumby SE, Gutteridge JMC, Evans TW. Pulmonary vascular permeability after cardiopulmonary bypass and its relationship to oxidative stress. Crit Care Med 1997; 25: 425-29.
7. Sinclair DG, Haslam PL, Quinlan GJ, Pepper JR, Evans TW. The effect of cardiopulmonary bypass on intestinal and pulmonary endothelial permeability. Chest 1995; 108: 718-24.
8. Byrick RJ, Noble WH. Postperfusion lung syndrome. Comparison of Travenol bubble and membrane oxygenators. J Thorac Cardiovasc Surg 1978; 76: 685-93.
9. Gillinov AM, Redmond JM, Winkelstein JA et al. Complement and neutrophil activation during cardiopulmonary bypass: a study in the complement-deficient dog. Ann Thorac Surg 1994; 57: 345-52.
10. Dancy CM, Townsend ER, Boylett A, Chan SL, Parker-Williams J, Parker DJ. Pulmonary dysfunction associated with cardiopulmonary bypass: a comparison of bubble and membrane oxygenators. Circulation 1981; 64(suppl II): II54-57.
11. Tonz M, Mihaljevic T, von Segesser LK, Fehr J, Schmid ER, Turina M. Acute lung injury during cardiopulmonary bypass. Are the neutrophils responsible? Chest 1995; 108: 1551-56.
12. Redmond JM, Gillinov AM, Stuart RS et al. Heparin-coated bypass circuits reduce pulmonary injury. Ann Thorac Surg 1993; 56: 474-79.
13. Zehr KJ, Poston RS, Lee PC et al. Platelet activating factor inhibition reduces lung injury after cardiopulmonary bypass. Ann Thorac Surg 1995; 59: 328-35.
14. Friedman M, Wang SY, Sellke FW, Franklin A, Weintraub RM, Johnson RG. Pulmonary injury after total or partial cardiopulmonary bypass with thromboxane synthesis inhibition. Ann Thorac Surg 1995; 59: 598-603.
15. Hashimoto K, Miyamoto H, Suzuki K et al. Evidence of organ damage after cardiopulmonary bypass. The role of elastase and vasoactive mediators. J Thorac Cardiovasc Surg 1992; 104: 666-73.
16. Hachida M, Hanayama N, Okamura T et al. The role of leukocyte depletion in reducing injury to myocardium and lung during cardiopulmonary bypass. ASAIO J 1995; 41: M291-94.
17. Asimakopoulos G, Smith PL, Ratnatunga CP, Taylor KM. Lung injury and acute respiratory distress syndrome after cardiopulmonary bypass. Ann Thorac Surg 1999 (in press).
18. Mangano CM, Diamondstone LS, Ramsay JG, Aggarwal A, Herskowitz A, Mangano DT. Renal dysfunction after myocardial revascularization: risk factors, adverse outcomes and hospital resource utilization. The Multicenter Study of Perioperative Ischemia Research Group. Ann Intern Med 1998; 128: 194-203.
19. Zanardo G, Michielson P, Paccagnella A. et al. Acute renal failure in the patient undergoing cardiac operation. Prevalence, mortality rate and main risk factors. J Thorac Cardiovasc Surg 1994; 107: 1489-95.
20. Christenson JT, Aeberhard JM, Badel P et al. Adult respiratory distress syndrome after cardiac surgery. Cardiovasc Surg 1996; 4: 15-21.
21. Asimakopoulos G, Taylor KM, Smith PLC, Ratnatunga CP. Prevalence of acute respiratory distress syndrome after cardiopulmonary bypass. J Thorac Cardiovasc Surg 1999; 117: 620-21.
22. Andersson L-G, Jeppsson A, Bratteby L-E et al. Renal function during cardiopulmonary bypass: influence of the calcium entry blocker felodipine. Anesth Analg 1996; 83: 34-40.
23. Kulka PJ, Tryba M, Zenz M. Preoperative alpha2-adrenergic receptor agonists prevent the deterioration of renal function after cardiac surgery: results of a randomized, controlled trial. Crit Care Med 1996; 24: 947-52.
24. Andersson L-G, Bratteby L-E, Ekroth R et al. Renal function during cardiopulmonary bypass: influence of pump flow and systemic blood pressure. Eur J Cardiothorac Surg 1994; 8: 597-602.
25. Berger RL, Davis KB, Kaiser GC. Preservation of the myocardium during coronary artery bypass grafting. Circulation 1981; 64[part 2]: 61-66.
26. Biagoli B, Giomarelli P, Gnudi G et al. Myocardial function in early hours after coronary artery bypass grafting: comparison of two cardioplegic methods. Ann Thorac Surg 1993; 56: 1315-23.
27. Ko W, Zelano J, Isom W, Krieger KH. The effects of warm versus cold blood cardioplegia on endothelial function, myocardial function, and energetics. Circulation 1993; 88: 359-65.
28. Simon P, Mohl W, Neumann F, Owen A, Punzengruber C, Wolner E. Effects of coronary artery bypass grafting on global and regional myocardial function. J Thorac Cardiovasc Surg 1992; 104: 40-45.
29. Voci P, Bilotta F, Aronson S et al. Echocardiographic analysis of dysfunctional and normal myocardial segments before and immediately after coronary artery bypass graft surgery. Anesth Analg 1992; 75: 213-8.
30. Hennein HA, Ebba H, Rodriguez JL et al. Relationship of the proinflammatory cytokines to myocardial ischemia and dysfunction after uncomplicated coronary revascularization. J Thorac Cardiovasc Surg 1994; 108: 626-35.
31. Myers ML, Webb C, Moffatt M, McIver D, Del Maestro R. Activated neutrophils impair rabbit heart recovery after hypothermic global ischemia. Ann Thorac Surg 1992; 53: 247-52.
32. Wilson IC, Gardner TJ, DiNatale JM, Gillinov AM, Curtis WE, Cameron DE. Temporary leukocyte depletion reduces ventricular dysfunction during prolonged postischemic reperfusion. J Thorac Cardiovasc Surg 1993; 106: 805-10.
33. Hagland U, Hulten L, Ahren C, Lundgren O. Mucosal lesions in the human small intestine in shock. Gut 1975; 16: 979-84.
34. Hagland U. The splanchnic organs as the source of toxic mediators in shock. Prog Clin Biol Res 1988; 264: 135-45.
35. Ohri SK, Desai JB, Gaer JAR et al. Intraabdominal complications following cardiopulmonary bypass. Ann Thorac Surg 1991; 52: 826-31.
36. Ohri SK, Fleming J, Keogh BE, Becket J, Brannan J, Taylor KM. Cardiopulmonary bypass mediates oxygen free radical gut injury. Br Heart J 1993; 69: 86.
37. Landow L, Phillips DA, Heard SO, Prevost D, Vandersalm TJ, Fink MP. Gastric tonometry and venous oximetry in cardiac surgery patients. Crit Care Med 1991; 19: 1226-33.
38. Sinclair DG, Houldsworth PE, Keogh B, Evans TW. Gut permeability following bypass surgery: a randomized study comparing the effects of dopamine and dopexamine. Am J Respir Crit Care Med 1994; 149: A939.
39. Andersen LW, Landow L, Baek, Jansen E, Baker S. Association between gastric intramucosal pH and splanchnic endotoxin, antibody to endotoxin, and tumor necrosis factor-alpha concentration in patients undergoing cardiopulmonary bypass. Crit Care Med 1993; 21: 210-17.
40. Parrillo JE. Pathogenetic mechanisms of septic shock. N Engl J Med 1993; 328: 1471-77.
41. Cotram RS, Kumar V, Robbins SL. Inflammation and repair. Robbins Pathologic basis of disease, 5th edn. Philadelphia, PA: WB Saunders, 1994: 51-92.
42. Chenoweth DE, Cooper SW, Hugli TE et al. Complement activation during cardiopulmonary bypass: evidence for generation of C3a and C5a anaphylatoxins. N Engl J Med 1981; 304: 497-502.
43. Kirklin JK, Westaby S, Blackstone EH et al. Complement and the damaging effects of cardiopulmonary bypass. J Thorac Cardiovasc Surg 1983; 86: 845-57.
44. Edmunds LH Jr. Blood-surface interactions during cardiopulmonary bypass. J Card Surg 1993; 8: 404-10.
45. Irvine L, Sundaram S, Courtney JM, Taggart DP, Wheatley DJ, Lowe GD. Monitoring of factor XII activity and granulocyte elastase release during cardiopulmonary bypass. ASAIO Trans 1991; 37: 569-71.
46. Dapper F, Neppl H, Wozniac G et al. Influence of four different membrane oxygenators on inflammation-like processes during extracorporeal circulation with pulsatile and non-pulsatile flow. Eur J Cardiothorac Surg 1992; 6: 18-24.
47. Moore FD. Therapeutic regulation of the complement system in acute injury states. Adv Immunol 1994; 56: 267-99.
48. Moore Jr FD, Warner KG, Assousa S, Valeri CR, Khuri SF. The effects of complement activation during cardiopulmonary bypass. Ann Surg 1988; 208: 95-103.
49. Fujishima S, Aikawa N. Neutrophil-mediated tissue injury and its modulation. Intens Care Med 1995; 21: 277-85.
50. Albelda SM, Smith CW, Ward PA. Adhesion molecules and inflammatory injury. FASEB J 1994; 8: 504-12.
51. Weiss SJ. Tissue destruction by neutrophils. N Engl J Med 1989; 320: 365-76.
52. Fingerle-Rowson G, Auers J, Kreuzer E et al. Down-regulation of surface monocyte lipopolysaccharide-receptor CD 14 in patients on cardiopulmonary bypass undergoing aorta-coronary bypass operation. J Thorac Cardiovasc Surg 1998; 115: 1172-8.
53. Ernofsson M, Thelin S, Siegbahn A. Monocyte . tissue factor expression, cell activation, and thrombin formation during cardiopulmonary bypass: a clinical study. J Thorac Cardiovasc Surg 1997; 113: 576-84.
54. Hansch GM, Seitz M, Betz M. Effect of the late complement component C5b-9 on human monocytes: release of prostanoids, oxygen radicals and of a factor inducing cell proliferation. Int Arch Allergy Appl Immunol 1987; 82: 317-20.
55. Murakami K, Okajima K, Uchida M, Okabe H, Takatsuki K. Gabexate mesilate, a synthetic protease inhibitor, attenuates endotoxin-induced pulmonary vascular injury by inhibiting tumor necrosis factor production by monocytes. Crit Care Med 1996; 24: 1047-53.
56. Lahat N, Zlotnick AY, Shtiller R, Bar I, Merin G. Serum levels of IL-1, IL-6 and tumour necrosis factors in patients undergoing coronary artery bypass grafts or cholecystectomy. Clin Exp Immunol 1992; 89: 255-60.
57. Menasche P, Haydar S, Peynet J et al. A potential mechanism of vasodilation after warm heart surgery: The temperature-dependent release of cytokines. J Thorac Cardiovasc Surg 1994; 107: 293-99.
58. Engelman RM, Rousou JA, Flack JE III, Deaton DW, Kalfin R, Das DK. Influence of steroids on complement and cytokine generation after cardiopulomonary bypass. Ann Thorac Surg 1995; 60: 801-804.
59. Sawa Y, Shimazaki Y, Kadoba K et al. Attenuation of cardiopulmonary bypass-derived inflammatory reactions reduces myocardial reperfusion injury in cardiac operations. J Thorac Cardiovasc Surg 1996; 111: 29-35.
60. Steinberg BM, Grossi EA, Schwartz DS et al. Heparin bonding of bypass circuits reduces cytokine release during cardiopulmonary bypass. Ann Thorac Surg 1995; 60: 525-29.
61. Frering B, Phillip I, Dehoux M, Rolland C, Langlois JM, Desmonts JM. Circulating cytokines in patients undergoing normothermic cardiopulmonary bypass. J Thorac Cardiovasc Surg 1994; 108: 636-41.
62. Kawamura T, Wakusawa R, Okada K, Inada S. Elevation of cytokines during open heart surgery with cardiopulmonary bypass: participation of interleukin-8 and 6 in reperfusion injury. Canad J Anaesthesia 1993; 40: 1016-21.
63. John AE, Galea J, Francis SE, Holt CM, Finn A. Interleukin-8 mRNA expression in circulating leucocytes during cardiopulmonary bypass. Perfusion 1998; 13: 409-17.
64. Asimakopoulos G, Taylor KM. The effects of cardiopulmonary bypass on leukocyte and endothelial adhesion molecules. Ann Thorac Surg 1998; 66: 2135-44.
65. Dreyer WJ, Michael LH, Millman EE, Berens KL. Neutrophil activation and adhesion molecule expression in a canine model of open heart surgery with cardiopulmonary bypass. Cardiovascular Research 1995; 29: 775-81.
66. Le Deist F, Menasche P, Bel A, Lariviere J, Piwnica A, Bloch G. Patterns of changes in neutrophil adhesion molecules during normothermic cardiopulmonary bypass. A clinical study. Eur J Cardiothorac Surg 1996; 10: 279-83.
67. Thanos D, Maniatis T. NF kappa B: a lesson in family values. Cell 1995; 80: 529-32.
68. Karim M. Signal transduction from cell surface to nucleus in development and disease. FASEB J 1992; 6: 2581-90.
69. Kilbridge PM, Mayer JE, Newburger JW, Hickey PR, Walsh AZ, Neufeld EJ. Induction of intercellular adhesion molecule-1 and E-selectin mRNA in heart and skeletal muscle of pediatric patients undergoing cardiopulmonary bypass. J Thorac Cardiovasc Surg 1994; 107: 1183-92.
70. Tsang GMK, Allen S, Pagano D, Wong C, Graham TR, Bonser RS. von Willebrand factor and urinary albumin excretion are possible indicators of endothelial dysfunction in cardiopulmonary bypass. EurJ Cardiothorac Surg 1998; 13: 385-91.
71. Boldt J, Osmer Ch, Schindler E, Linke L-Ch, Stertmann W-A, Hempelmann G. Circulating adhesion molecules in cardiac operations: influence of high-dose aprotinin. Ann Thorac Surg 1995; 59: 100-105.
72. Weerwind PW, Maessen JG, van Tits LJH et al. Influence of Duraflo II heparin-treated extracorporeal circuits on the systemic inflammatory response in patients having coronary bypass. J Thorac Cardiovasc Surg 1995; 110: 1633-41.
73. Ashraf S, Butler J, Tian Y et al. Inflammatory mediators in adults undergoing cardiopulmonary bypass: comparison of centrifugal and roller pumps. Ann Thorac Surg 1998; 65: 480-84.
74. Quiroga MM, Miyagishima R, Haendschen LC, Glovsky M, Martin BA, Hogg JC. The effect of body temperature on leukocyte kinetics during cardiopulmonary bypass. J Thorac Cardiovasc Surg 1985; 90: 91-96.
75. Gu YJ, Mariani MA, van Oeveren W, Grandjean JG, Boonstra PW. Reduction of the inflammatory response in patients undergoing minimally invasive coronary artery bypass grafting. Ann Thorac Surg 1998; 65: 420-24.
76. Journois D, Pouard P, Greeley WJ, Mauriat P, Vouhe P, Safran D. Hemofiltration during cardiopulmonary bypass in pediatric cardiac surgery. Anesthesiology 1994; 81: 1181-89.
77. Johnson D, Thomson D, Hurst T et al. Neutrophil-mediated acute lung injury after extracorporeal perfusion. J Thorac Cardiovasc Surg 1994; 107: 1193-202.
78. Gu YJ, deVries AJ, Boonstra PW, van Oeveren W. Leukocyte depletion results in improved lung function and reduced inflammatory response after cardiac surgery. J Thorac Cardiovasc Surg 1996; 112: 494-500.
79. Hill GE, Alonso A, Spurzem JR, Stammers AH, Robbins RA. Aprotinin and methylprednisolone equally blunt cardiopulmonary bypass-induced inflammation in humans. J Thorac Cardiovasc Surg 1995; 110: 1658-62.
80. Hill GE, Snider S, Galbraith TA, Forst S, Robbins RA. Glucocorticoid reduction of bronchial epithelial inflammation during cardiopulmonary bypass. Am J Respir Crit Care Med 1995; 152: 1791-95.
81. Markewitz A, Faist E, Lang S, Endres S, Hultner L, Reichart B. Regulation of acute phase response after cardiopulmonary bypass by immunomodulation. Ann Thorac Surg 1993; 55: 389-94.
82. Seghaye M-C, Duchateau J, Grabitz RG et al. Effect of sodium nitroprusside on complement activation induced by cardiopulmonary bypass: a clinical and experimental study. J Thorac Cardiovasc Surg 1996; 111: 882-92.
83. Lefer AM, Lefer DJ. The role of nitric oxide and cell adhesion molecules on the microcirculation in ischaemia-reperfusion. Cardiovasc Res 1996; 32: 743-51.
84. Friedman M, Wang SY, Sellke FW, Cohn WE, Weintraub RM, Johnson RG. Neutrophil adhesion blockade with NPC 15669 decreases pulmonary injury after total cardiopulmonary bypass. J Thorac Cardiovasc Surg 1996; 111: 460-68.
85. Dreyer WJ, Michael LH, Millman EE, Berens KL, Geske RS. Neutrophil sequestration and pulmonary dysfunction in a canine model of open heart surgery with cardiopulmonary bypass. Evidence for a CD 18-dependent mechanism. Circulation 1995; 92: 2276-83.